Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools Obesity

Obesity

Programs, trials, and reported weight change for obesity and overweight.

Data as of 11.07.2026

All studies

HDM1002

Evaluate the Safety and Efficacy of HDM1002 Tablets in Overweight and Obese Adults

Huadong Medicine · Phase 2 · Status n/r · Enrollment 180

NCT06500299

Participants reaching a weight loss threshold

Participants reaching threshold, %

Source: Cited trial source. The denominator is the source figure, when it states one.

No selected arm reports a responder percent.

Show as table
Arm≥5%≥10%≥15%≥20%
HDM1002 100mg BIDn/rn/rn/rn/r
HDM1002 200mg BIDn/rn/rn/rn/r
HDM1002 400mg QDn/rn/rn/rn/r
placebon/rn/rn/rn/r

Not shown

  • HDM1002 100mg BID: endpoint not reported
  • HDM1002 200mg BID: endpoint not reported
  • HDM1002 400mg QD: endpoint not reported
  • placebo: endpoint not reported